A dose of AI
From our UK edition
Perhaps in common with many people who don’t work in pharmaceuticals, I vaguely imagined that the industry found much of its inspiration from nature. Scientists might start with an old wives’ tale that, say, cowslips cure genital warts, and then work towards medicalising it — searching for an active ingredient which can then be synthesised, tested and ultimately marketed as a sterile pill in a little cardboard box, to be taken three times a day. That was, indeed, how some common drugs were developed — and how some still are, most notably with efforts to make medical use of the constituents of cannabis plants. Yet this ignores the fact that the great bulk of modern drugs are increasingly being identified via theoretical work.